Page last updated: 2024-09-05

lapatinib and malondialdehyde

lapatinib has been researched along with malondialdehyde in 1 studies

Compound Research Comparison

Studies (lapatinib)	Trials (lapatinib)	Recent Studies (post-2010) (lapatinib)	Studies (malondialdehyde)	Trials (malondialdehyde)	Recent Studies (post-2010) (malondialdehyde)
1,919	305	1,442	27,849	1,405	13,922

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akgullu, C; Aksun, S; Bilgen, M; Boyacioglu, M; Demirci, B; Eryilmaz, U; Ilgenli, TF; Yalinkilinc, HS	1

Other Studies

1 other study(ies) available for lapatinib and malondialdehyde

Article	Year
S100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers. PloS one, 2015, Volume: 10, Issue:12 Topics: Animals; Antineoplastic Agents; Biomarkers; Catalase; Glutathione; Heart Failure; Lapatinib; Male; Malondialdehyde; Myocardium; Neoplasms; Oxidative Stress; Quinazolines; Rats, Wistar; S100 Proteins; Superoxide Dismutase; Trastuzumab	2015

Article

Year

S100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers.

PloS one, 2015, Volume: 10, Issue:12

Topics: Animals; Antineoplastic Agents; Biomarkers; Catalase; Glutathione; Heart Failure; Lapatinib; Male; Malondialdehyde; Myocardium; Neoplasms; Oxidative Stress; Quinazolines; Rats, Wistar; S100 Proteins; Superoxide Dismutase; Trastuzumab

2015